Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study.

Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study.

<h4>Objective</h4>To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naïve patients with branch retinal vein occlusion (BRVO) enrolled in the LUMINOUS™ study.<h4>Study design</h4>A 5-year, global, prospective, multicenter, observa...

Full description

Bibliographic Details
Main Authors: Ian Pearce, Andreas Clemens, Michael H Brent, Lin Lu, Roberto Gallego-Pinazo, Angelo Maria Minnella, Catherine Creuzot-Garcher, Georg Spital, Taiji Sakamoto, Cornelia Dunger-Baldauf, Ian L McAllister, all the LUMINOUS™ study investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0234739

Internet

https://doi.org/10.1371/journal.pone.0234739

Similar Items